Clinical Trial

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
Protocol Amendment History 139 amendments
This ClinicalTrials.gov record has been amended 139 times since 2016-11-01; most recent amendment 2026-04-14.
Status change: Recruiting → Active, Not Recruiting 2025-12-09
Status change: Active, Not Recruiting → Recruiting 2021-09-01
Status change: Recruiting → Active, Not Recruiting 2020-07-22
Status change: Not Yet Recruiting → Recruiting 2016-12-15
Trial Details
NCT Number NCT02954094
Lead Sponsor Target PharmaSolutions, Inc.
Conditions Hepatocellular Cancer
Enrollment 10,000 participants
Start Date 2016-12
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-17